Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratumoral Urelumab and Nivolumab in Advanced Solid Tumors
NCT03792724Phase 2Unknown
- Sponsor
- Universidad de Navarra
- Start
- Jan 2019
- Primary completion
- Jan 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label trial of urelumab in solid tumor (advanced stage), sponsored by Universidad de Navarra. Status: unknown.
02
Drugs
urelumab
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT03792724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03792724.